Popular on Amzeal
- ProStrategix Proud To Announce Being Chosen as a Top Web Design Agency by DesignRush
- Romance Scams. Senior Women Hit the Hardest - Be Smarter Than Your Phone Cyber Security Podcast
- HLN Releases Open Source Vaccine Provider Agreement System
- You, Google, Microsoft, Facebook Should Use This New Tech For More Growth In The World
- New York State Small Business Owner Molly Bakewell Chamberlin Appointed to Washington, D.C.-Based NSBA Leadership and Technology Councils
- A Special New Spark Design Award Announced
- Business Owners Can Find System Flaws Before Cyber Criminals Do with the No-Cost Discovery Assessment from Infoaxis
- BrainKraft and career.pm Announce Product Launch Partnership
- Techspert Services IT Support is now available in Tampa, FL
- Daly joins Jigsaw24 in partner push
Similar on Amzeal
- Julia Hair Tax Refund Season Flash Sale Week With Buy Now Pay Later
- Zilker Partners Acquires Growth Digital, Forming One-of-a-Kind Firm
- Tech Startup to Offer Up To 100% Funding Aid to Individuals for Covering Their Education or Travel Expenses
- 2021 Marketing Excellence Awards—Call for Entries: Honoring the Best in B2B Services and Solutions Marketing
- Delray Beach Branding Agency Celebrates Women in Business on International Women's Day
- Ideanomics Announces Its Membership in CALSTART
- Syxsense Announces Integration with Microsoft Office 365
- Launch of Trace One E-Sourcing Will Boost Retailers' Private Label Speed to Market
- Thru-hikers Launch New Nature Streaming TV Channel for Nature Lovers
- Fennemore Names New Office Managing Partners, Practice Group Leaders & Chief Diversity Officer
Abond CRO Announces That Mr. Zoran Antonijevic Is Their New Vice President, Statistical Consulting
Amzeal News/10406147
ALLENDALE, Mich.--(BUSINESS WIRE)--Dr. Phil Doren, Chief Executive Officer and Vice President, is pleased to announced today that Zoran Antonijevic is the Vice President, Statistical Consulting at Abond CRO Inc. "With this single appointment, we have greatly strengthened our capability to address customers' needs in statistical consulting for drug development," Doren said.
Mr. Antonijevic is an industry thought leader with cutting edge knowledge of innovative methods and strategies including adaptive design, platform trials, and program/portfolio optimization. He has extensive experience with drug development, department development and decision making. He is the long-time Chair and leader of the DIA Adaptive Design Scientific Working Group. His background covers numerous therapeutic areas and his professional strengths include development strategy, thought leadership and vision, consulting, program and portfolio level optimization, master protocols, decision science, analytics, due diligence, regulatory, department vision, processes and metrics and talent identification.
More on Amzeal News
Prior to coming to Abond CRO, Mr. Antonijevic's CRO experience included leading Biometrics, where he managed all biostatistics, programming, data management and medical writing activities, and previously he was Senior Director of Strategy, and the Senior Director/Director, Center for Statistics in Drug Development Innovation.
His experience at major pharmaceutical companies includes Innovative & Adaptive Design Executive Director and Head of Development Design Center, and, very early in his career, was a Principal Statistician.
Mr. Antonijevic formed his own consulting company and while doing that work, served as Chief Scientific Officer for a global health firm specializing in highly-efficient clinical study designs and biostatistical methods. He began his career at the Harvard School of Public Health, AIDS Clinical Trials Group (ACTG).
"Abond CRO is excited to have Zoran join our company. His leadership, experience and amazing technical expertise greatly enhances our foundational and long-standing tradition of excellent direction and support in statistical consulting for our customers," Doren added.
More on Amzeal News
About Abond CRO Inc. (www.abondcro.com)
Abond is a full-service clinical research organization dedicated to providing specialized clinical research support for the pharmaceutical and medical device industries since its founding in 1974 (incorporation in 1985). They deliver everything you'd expect from a full-service CRO — consulting, clinical operations, data management, statistical analysis — and a few things that set them apart: honesty, focus, and responsibility. Abond works with small startup organizations to established pharmaceutical and medical device leaders around the world.
Mr. Antonijevic is an industry thought leader with cutting edge knowledge of innovative methods and strategies including adaptive design, platform trials, and program/portfolio optimization. He has extensive experience with drug development, department development and decision making. He is the long-time Chair and leader of the DIA Adaptive Design Scientific Working Group. His background covers numerous therapeutic areas and his professional strengths include development strategy, thought leadership and vision, consulting, program and portfolio level optimization, master protocols, decision science, analytics, due diligence, regulatory, department vision, processes and metrics and talent identification.
More on Amzeal News
- Now Available at NeoMetrix Technologies, the NEW peel 2S
- ConvergeOne and Evolve IP Enter Strategic Hospitality Partnership
- Alliance Technologies Launches Alliance University
- Home2 Suites by Hilton Tucson Airport Celebrates Topping Off - Tucson's Newest Extended-Stay Hotel
- Truthset and the ANA AIMM Release First of its Kind Multicultural Online Data Benchmarks
Prior to coming to Abond CRO, Mr. Antonijevic's CRO experience included leading Biometrics, where he managed all biostatistics, programming, data management and medical writing activities, and previously he was Senior Director of Strategy, and the Senior Director/Director, Center for Statistics in Drug Development Innovation.
His experience at major pharmaceutical companies includes Innovative & Adaptive Design Executive Director and Head of Development Design Center, and, very early in his career, was a Principal Statistician.
Mr. Antonijevic formed his own consulting company and while doing that work, served as Chief Scientific Officer for a global health firm specializing in highly-efficient clinical study designs and biostatistical methods. He began his career at the Harvard School of Public Health, AIDS Clinical Trials Group (ACTG).
"Abond CRO is excited to have Zoran join our company. His leadership, experience and amazing technical expertise greatly enhances our foundational and long-standing tradition of excellent direction and support in statistical consulting for our customers," Doren added.
More on Amzeal News
- Julia Hair Tax Refund Season Flash Sale Week With Buy Now Pay Later
- The Best Virgin Hair Vendors 2021
- ACS Lawyer In Brooklyn Announces Dismissal of OCFS Case
- Infosec's Choose Your Own Adventure® Security Awareness Games win Achievement of the Year in Video
- Liquid Core® Gum Company announces TDA Boulder Creative Director Jonathan Schoenberg has joined its Advisory Board
About Abond CRO Inc. (www.abondcro.com)
Abond is a full-service clinical research organization dedicated to providing specialized clinical research support for the pharmaceutical and medical device industries since its founding in 1974 (incorporation in 1985). They deliver everything you'd expect from a full-service CRO — consulting, clinical operations, data management, statistical analysis — and a few things that set them apart: honesty, focus, and responsibility. Abond works with small startup organizations to established pharmaceutical and medical device leaders around the world.
Filed Under: Business
0 Comments
Latest on Amzeal News
- Construction Technology Startup Mosaic Hires Real Estate Veteran as First CFO
- First look: Clark Nexsen completes engineering building at NC State University
- Orchestry Announces Partnership with Softchoice to Make Work Simple in Microsoft 365
- Barcoding, Inc. Announces Partnership with Ignition by TELUS and Exceedra by TELUS
- New vertical screen gaming machine models increase attraction
- ACEINNA Names Michael DiGangi as Executive VP
- 2021 Marketing Excellence Awards—Call for Entries: Honoring the Best in B2B Services and Solutions Marketing
- edjuster Launches Fully Interactive Digital Contents Claims Portal
- Senseeker Engineering Acquires SE-IR Corporation
- VIZGARD Joins NVIDIA's Accelerator for AI Start-ups
- eMoney Advisor Veterans Start Firm to Help Fintech CEOs Jump Start Growth
- ChartSpan Names Keith Lynn, Chief Technology Officer
- Wink, Link and Meet for a Drink! The Newest Meet Now App has Arrived!
- Florida small town festival ranks Top 50 BEST in nation
- Ordyx POS Brings Exciting New Features With Launch of OrdyxOne, Their Latest Software Update
- Delray Beach Branding Agency Celebrates Women in Business on International Women's Day
- Field Force Tracker Enhances Contract Management for Fire Control and Security Monitoring Companies
- Digital Cash Processing, Genmega Partner to Deliver Next Generation ATM Functionality
- Nationally Syndicated Radio Show "Radio Bassment" Launching Daily Programming 7 Days a Week
- AKCP Adds RADIUS Authentication Protocols to SP2+ and SPx+